Heron Therapeutics (AXD2) Q2 2021 Earnings Report
4 Followers
DE:AXD2 Q2 2021 EPS Results
- Actual EPS
- -EUR 0.55
- Consensus EPS
- -EUR 0.50
- Beat/Miss
- Missed by -EUR 0.06
- One Year Ago EPS
- -EUR 0.54
DE:AXD2 Q2 2021 Revenue Results
- Actual Revenue
- EUR 20.02M
- Expected Revenue
- EUR 26.27M
- Beat/Miss
- Missed by -EUR 6.25M
- YoY Revenue Growth
- -0.99%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/09/2021
- Time
- Before Open
- Conference Call
- Monday, August 9, 2021
DE:AXD2 Upcoming Earnings
Heron Therapeutics's next earnings date is estimated for November 9, 2026, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:AXD2 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 09, 2026 | 2026 (Q3) | -0.02- | -0.09 | ― | ― |
| Aug 10, 2026 | 2026 (Q2) | -0.00-0.03 | -0.02 | -50.00% (-0.01) | |
| May 11, 2026 | 2026 (Q1) | -0.02-0.04 | 0.01 | -500.00% (-0.04) | |
| Feb 26, 2026 | 2025 (Q4) | -0.02-0.02 | 0.02 | -200.00% (-0.04) | |
| Nov 04, 2025 | 2025 (Q3) | -0.01-0.09 | -0.03 | -233.33% (-0.06) | |
| Aug 08, 2025 | 2025 (Q2) | -0.01-0.02 | -0.05 | 66.67% (+0.04) | |
| May 06, 2025 | 2025 (Q1) | -0.010.01 | -0.02 | 150.00% (+0.03) | |
| Feb 27, 2025 | 2024 (Q4) | -0.030.02 | -0.06 | 128.57% (+0.08) | |
| Nov 12, 2024 | 2024 (Q3) | -0.03-0.03 | -0.15 | 82.35% (+0.12) | |
| Aug 06, 2024 | 2024 (Q2) | -0.03-0.05 | -0.31 | 82.86% (+0.26) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
